Azafaros is a clinical-stage company developing innovative therapies for rare lysosomal storage disorders, including Niemann-Pick disease Type C and GM1/GM2 gangliosidoses.

Be.EV is a UK-based company that develops and operates electric vehicle charging networks, focusing on installing ultra-rapid charging bays at retail and leisure properties.

HAYA Therapeutics develops precision RNA-guided therapeutics targeting long non-coding RNA for treating aggressive solid tumors and other diseases.

Luminance is a legal AI company that leverages artificial intelligence to assist legal professionals with document review and analysis.

Poolside is an AI-powered software development platform that provides tools for code autocompletion and other development tasks, primarily serving Global 2000 companies and public-sector agencies.

Memo Therapeutics is a late-stage biotech company that has raised CHF 25M in a Series C funding round to develop its antibody, AntiBKV, and advance its existing antibody pipeline.